Eloxx Pharmaceuticals, Inc. (NasdaqCM: ELOX)
Health Care · Pharmaceuticals · US
$13.74
-11.41% today · +1250127.5% 1Y
Eloxx Pharmaceuticals, Inc. (NasdaqCM: ELOX) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $55.46M and employs 10 people.
Over the last twelve months the share price has gained 1250127.5%, trading between 0.00 and 23.40.
Tweenvest scores Eloxx Pharmaceuticals, Inc. across four factors: quality 19/100, value 32/100. Its strongest factor is value.
ELOX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $55.46M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -2.84
- Dividend yield
- —
- Beta (5Y)
- -171,310.26
- 52-week high
- $23.40
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 4.04M
- Employees
- 10
- Next earnings
- —
About Eloxx Pharmaceuticals, Inc.
Eloxx Pharmaceuticals is a clinical-stage biopharmaceutical firm that specializes in developing therapeutic solutions through ribosome modulation. Its primary objective is to address rare and ultra-rare genetic diseases that arise from premature stop codons. The company's most advanced investigational compound, ELX-02, is currently progressing through Phase 2 clinical trials. This candidate is being evaluated for its potential to treat patients with cystic fibrosis and nephropathic cystinosis who possess diagnosed nonsense mutations. In addition to its lead program, Eloxx is actively pursuing several preclinical projects aimed at conditions like Alport syndrome, recessive dystrophic epidermolysis bullosa, junctional epidermolysis bullosa, and familial adenomatous polyposis. The company also maintains various earlier-stage discovery initiatives focused on oncology. Eloxx Pharmaceuticals was established in 2013 and is headquartered in Watertown, Massachusetts.
- ISIN
- US29014R3012
- Founded
- 1999
- Listed since
- Jun 9, 2026
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| OPC Pharmaceutical Joint Stock CompanyHOSE: OPC | $57.55M | ₫19,950.00 | -0.25% |
| CKD Bio Corp.KOSE: A063160 | $57.17M | ₩14,010.00 | +9.54% |
| Sunny Pharmtech Inc.TPEX: 6676 | $57.05M | NT$10.75 | -2.27% |
| Talphera, Inc.NasdaqCM: TLPH | $56.06M | $1.09 | +0.93% |
| K Pharma,Inc.TSE: 4896 | $55.27M | ¥753.00 | +0.40% |
| Sinil Pharmaceutical Co., Ltd.KOSDAQ: A012790 | $55.09M | ₩6,510.00 | +0.46% |
| Chi Sheng Pharma & Biotech Co., LtdTPEX: 4111 | $54.27M | NT$29.00 | +1.05% |
| LeonaBio, Inc.NasdaqCM: LONA | $54.17M | $6.14 | +6.78% |
Figures last refreshed Oct 11, 2026.